Do Ketone Drinks Improve Immune, Metabolic and Cognitive Health in Older Adults
Key claim: A randomised, double-blind, placebo-controlled trial is testing whether four weeks of thrice-daily ketone monoester drinks improve metabolic, inflammatory, immune, adipose-tissue, and cognitive markers in adults aged 60–80.
Abstract
The goal of this randomised, double-blinded, placebo-controlled trial is to investigate the immune, metabolic and cognitive effects of four weeks of daily ketone supplementation in adults aged 60 to 80 with stable health. The main objectives are to assess the effects of the intervention versus placebo on markers of metabolic health, inflammation, immune function, adipose tissue, and cognitive performance.
Participants will undergo two weeks of baseline monitoring followed by a four-week supplementation period in which they will drink a ketone monoester drink or taste-matched placebo three times a day. During these periods, participants will record their diet and supplement intake and their physical activity and blood glucose will be monitored using wearable devices. At the beginning and end of the supplementation period, participants will undergo testing in the university physiology laboratories, involving blood, expired air and adipose tissue samples, as well as cognitive tests, physical tests and questionnaires.
Why this matters
Exogenous ketone drinks have spread through biohacking and endurance-athlete channels largely on mechanism and anecdote; a double-blind placebo-controlled trial in adults 60–80 with metabolic, immune, adipose, and cognitive endpoints is one of the first attempts to test the longevity-adjacent claims in the demographic those claims most often target. The protocol registration itself is not evidence — it is a signal that the trend is entering controlled evaluation, and the divergence between current marketing and the still-pending readout is the story to track.